Home

Dongkook Pharmaceutical Co., Ltd. sell "Octreotide Acetate LAR Injection"

A10C07

Basic Information

257
19
3
4.0(42)

Trade Type

Sell

Product Name

Octreotide Acetate LAR Injection

Specifications

  • Indication: Long-acting release (LAR) somatostatin analogue for acromegaly, carcinoid tumors and VIPoma.
  • Dosage Form: Long-acting release (LAR) microsphere suspension for intramuscular injection, intended for the labeled route of administration.
  • Storage Conditions: Store refrigerated at 2–8°C, protected from light; do not freeze. May be kept at room temperature (up to 25°C) for a limited period prior to reconstitution per product labeling.
  • Regulatory Approval Status: Manufactured under GMP-compliant quality systems; marketed in the Republic of Korea and other jurisdictions under national marketing authorization.

Other Information

Additional Description:

Octreotide acetate injection for acromegaly, carcinoid tumors and VIPoma.
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product